ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NMDP Named ‘Best Place to Work’ Fifth Year in a Row

MINNEAPOLIS, Aug. 22, 2025 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, announced the Minneapolis / St. Paul Business Journal honored the organization for the fifth consecutive year as a top workplace, notching 4th place in the 'extra large' company category of 2025 Best Places to Work, which recognizes Twin Cities-based organizations that excel at creating positive, thriving environments for their employees.

Since its inception in 1987, NMDP has grown from a small team into a global workforce dedicated to saving lives. Today, nearly 1,000 employees in Minnesota and more than 800 colleagues worldwide collaborate to support patients and families facing life-threatening blood cancers and diseases. Through groundbreaking cell therapy research, donor registry management, reliable infrastructure and logistics, transplant center network, patient and care-giver advocacy and support, and technological innovation, the Twin Cities-founded nonprofit has impacted more than 140,000 lives through cell therapy—giving a second chance to patients at home and abroad.

“What inspires me most after being at NMDP for over ten years is our people—their heart, their drive, and their unwavering belief in what we do,” said Amy Ronneberg, CEO of NMDP. “Every team member plays a critical role in helping patients access their life-saving cell therapy, and it’s that shared purpose that makes this one of the best places to work. We’re more than colleagues—we’re a community united by hope, and every day, our employees show what’s possible when compassion and commitment come together.”

Living Out Our Mission

For many NMDP employees, the organization’s mission is personal. Forty-one current employees have donated potentially life-saving blood stem cells; seven have received these donations themselves, often inspiring them to choose careers at NMDP. About 150 serve as professionally-trained couriers, spending their time carefully transporting donated cells to transplant centers across the U.S. and world to ensure patients can have a second chance at life.

One example of this selfless dedication is NMDP employee Libby Seering, who serves as a senior project coordinator for enterprise initiatives that advance infrastructure and long-term goals. She is also a blood stem cell donor, helping to save the life of a complete stranger, who is now five years post transplant and grateful for more time with his wife, children and grandchildren. Seering had the opportunity to meet her recipient earlier this year and the two share an unbreakable bond.

“What makes NMDP special isn’t just our mission, it’s the people who bring it to life every day. Their unwavering commitment propels us toward our vision—creating a world where every patient can receive their life-saving cell-therapy,” said Ronneberg. “It’s our collective commitment to donors, patients, volunteers, supporters, and partners that enables us to advance breakthrough research, deliver superior service, and expand equitable access to transplant. Being recognized as a Best Place to Work for five consecutive years is a testament to the unique culture we’ve created together—and it propels us toward our five-year goals of impacting 10,000 patient lives annually.”

Discover more about the people behind our mission and opportunities to join us at nmdp.org/careers.

About the 2025 Minneapolis / St. Paul Business Journal 'Best Places to Work' Awards

Together with Omaha, Neb.-based Quantum Workplace, the Minneapolis / St. Paul Business Journal identified 70 companies in the region that scored high marks from their employees when asked to rate their employers on a variety of questions related to leadership, communication and more. The honorees are ranked by their employee survey score in the August 22 Best Places to Work special publication of the Journal, featuring all 70 winners.

About NMDP

At NMDP, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives. Learn more at nmdp.org.

Contact:
Erin Bix
ebix@nmdp.org


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.